Most analysts are positive but target prices indicate limited upside
Apollo Hospitals to acquire Excelcare for Rs 210 crore
The healthcare major on Friday reported an over fourfold jump in its consolidated net profit
Apollo Hospitals, in a statement, said, however, it is an "indicative list" and the "final list of co-morbidities eligible for free vaccination would be as per the list published by the government"
Apollo Hospitals said the Covid-19 pandemic highlighted the challenges faced by the country with regard to infrastructure to provide critical care to patients.
In the past one week, Apollo Hospitals Enterprises, Fortis Healthcare and Max Healthcare have surged between 12 per cent and 15 per cent as compared to a 2 per cent rise in the S&P BSE Sensex
Expansion potential in digital platform, steady growth in traditional business and value unlocking in pharmacy segment are key positives
Apollo Hospitals treated over 1,50,000 Covid-19 patients with over 5,000 beds dedicated during the peak
A leading hospital group on Tuesday announced that it will conduct a pan-India Covid vaccination drive on June 30 spanning 50 cities, to boost the national inoculation exercise.
Apollo will merge its online and offline pharmacy businesses (excluding hospital pharmacies) and telemedicine verticals into a single entity called Apollo HealthCo
Will look at acquisitions after monetising a small stake
The shares of Shyam Metalics and Sona Comstar are slated to list on the bourses on Thursday. A strong debut is on the cards for Shyam Metalics while Sona Comstar is likely to witness a muted listing
Healthcare chain Apollo Hospitals Enterprise Ltd on Wednesday reported a consolidated net profit of Rs 169.89 crore for the fourth quarter ended March 31, 2021. The company, which posted a consolidated net profit of Rs 209.60 crore in the corresponding quarter of the previous fiscal, also announced a re-organisation with the formation Apollo HealthCo, with the aim of "creating India's largest omni-channel healthcare platform". Consolidated revenue from operations in the fourth quarter stood at Rs 2,867.95 crore in the quarter under review. It was Rs 2,922.43 crore in the year-ago period, Apollo Hospitals Enterprise Ltd (AHEL) said in a regulatory filing. For the fiscal ended March 31, 2021, the company said its consolidated net profit stood at Rs 136.77 crore. It was at Rs 431.80 crore in FY20. Consolidated revenue from operations for FY21 was at Rs 10,560.01 crore. It was at Rs 11,246.80 crore in FY20, the filing said. The company said the divestment of its front-end retail pharm
An official had earlier said the hospital would start giving Sputnik V jabs by June 20
Apollo Hospitals on Tuesday announced an initiative to provide home-quarantined Covid-19 patients medical care
The antibody cocktail is administered intravenously and will be administered in a specific area with well-trained healthcare staff taking into account all infection control protocols
The changes are likely during the half-yearly review undertaken by MF industry body Amfi during July first week
Apollo Hospitals and Dr Reddy's Laboratories on Monday said they are collaborating to initiate a COVID-19 vaccination programme in the country with Sputnik V. The first phase of the programme will kick off with vaccinations in Hyderabad on Monday and in Visakhapatnam on Tuesday (May 18) at Apollo facilities. The vaccinations would follow the SOPs as recommended by the government including registration on CoWIN. Apollo Hospitals' Joint Managing Director Sangita Reddy said the healthcare major would receive 10 lakh doses of the COVID-19 vaccine over a period of one month. "Delighted to share @HospitalsApollo has Ptnr with @drreddys 2 admin #SputnikV the 1st foreign-made #vaccine to be used in #India to all DRL staff. Additionally, we will be receiving 1 Mn doses (over 1 mth period ) 4 our public #vaccinationdrive as #IndiaFightsCOVID19," she tweeted. For the pilot programme, Apollo would receive the Sputnik V vaccines from the first batch of 1.5 lakh doses imported by Dr Reddy's s
Two major hospital groups, Apollo Hospitals and Fortis Healthcare, said they are open to exploring opportunities to import
The third and the largest phase of vaccination, under which beneficiaries in the 18-45 age group will be given jabs against coronavirus, will begin here on Monday